A common G10430A mutation (Gly 60 Ser) in the factor IX gene describes the presence of moderate and mild hemophilia B in the majority of the Gujarati population

Annals of Hematology

Volumn 86, Issue 5, 2007, Pages 377-379

  Quadros, Leera ^a   Ghosh, Kanjaksha ^a   Shetty, Shrimati ^a  

^a KEM HOSPITAL   (India)

Author keywords

EGF likedomain; Exon d; Hemophilia B

Indexed keywords

BLOOD CLOTTING FACTOR 9; DNA; EPIDERMAL GROWTH FACTOR; GLYCINE; SERINE;

AMINO ACID SUBSTITUTION; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DISEASE SEVERITY; DNA EXTRACTION; DNA SEQUENCE; EXON; FOUNDER EFFECT; GENE AMPLIFICATION; GENE MUTATION; HAPLOTYPE; HEMOPHILIA B; HETEROZYGOTE DETECTION; HUMAN; INDIA; MALE; POLYMERASE CHAIN REACTION; POPULATION RESEARCH; PRENATAL DIAGNOSIS; PRIORITY JOURNAL; SEQUENCE ANALYSIS;

DNA MUTATIONAL ANALYSIS; FACTOR IX; FOUNDER EFFECT; HEMOPHILIA B; HETEROZYGOTE; HUMANS; INDIA; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 33947608488     PISSN: 09395555     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00277-007-0250-5     Document Type: Article

References (16)

1. Gianelli F, Green P, High KA, Lozier JN, Lillcrap DP, Ludwig M, Olek K, Rerstma PH, Goosens M, Yoshioka A, Sommer S, Brownlee GG (1999) Haemophilia B: Database of point mutations and short additions and deletions. Nucleic Acids Res 18:4053-4059
2. Bottema CDK, Koeberl DD, Ketterling RP, Bowie EJW, Taylor SAM, Lillicrap D, Shapiro A, Gilchrist G, Sommer SS (1990) A past mutation of isoleucine 397 is now a common cause of moderate-mild hemophilia. Br J Haematol 75:212-216
3. Geddes VA, Le Bonniec BF, Louie GV (1989) A moderate form of hemophilia B is caused by a novel mutation in the protease domain of factor IX-Vancouver. J Biol Chem 264:4689-4697
4. Thompson AR, Bajaj SP, Chen SH, Macgillivray RTA (1990) Founder effect in different families with hemophilia B mutation. Lancet 2:418
5. Sambrook J, Russell DW (2001) Molecular cloning, a laboratory manual, 3rd edn. Cold Spring Harbor Press, Cold Spring Harbor, NY, p 68
6. Hinks JL, Winship PR, Makis M, Preston IR, Goodeve AC (1999) A rapid method for haemophilia B mutation detection using CSGE. Br J Haematol 104:915-918
7. Saiki RK, Gelfand DH, Stoffel S, Scharf SJ, Higuchi R, Horn GT, Mullis KB, ERrlich HA (1988) Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase. Science 239:487-491
8. Jayandharan G, Shaji RV, Chandy M, Srivastava A (2003) Identification of factor IX gene defects using a multiplex PCR and CSGE strategy - a first report. Thromb Haemost 1:2051-2054
9. Williams IJ, Abuzendah A, Winship PR, Preston FE, Dolan G, Wright J, Peake IR, Goodeve AC (1998) Precise carrier and prenatal diagnosis in families with hemophilia A. Use of conformation sensitive gel electrophoresis for rapid mutation screening and polymorphism analysis. Thromb Haemost 79:723-726
10. Winship PR et al (1989) Detection of polymorphisms at cytosine phosphoguanidine polymorphisms dinucleotides and diagnosis of hemophilia B carriers. Lancet I 631-634
11. Winship PR et al (1993) An Mse 1 RFLP in the flanking region of the factor IX gene: Its use for hemophilia B carrier detection in Caucasian and Thai populations. Br J Haematol 84:101-105
12. Bowen et al (1991) Facile and rapid analysis of three DNA polymorphisms within the human factor IX gene using the polymerase chain reaction. Br J Haematol 77:559-560
13. Toyozumi et al (1995) Diagnosis of hemophilia B carriers using two novel oligonucleotide polymorphisms and Hha 1 RFLP of the factor IX gene in Japanese subjects. Thromb Haemost 74:1009-1014
14. Peake IR, Lillicrap DP, Bouljenkov V, Briet E, Chan V, Ginter EK, Kraus EM, Ljung R, Mannucci PM, Nicolaides K, Tuddenham EGD (1993) Hemophilia: strategies for carrier detection and prenatal diagnosis. Bull WHO 71:429-458
15. Denton DH, Fowlkes DM, Lord ST, Reissner HM (1988) Hemophilia B Durham: a mutation in the first EGF-like domain of factor IX that is characterized by polymerase chain reaction. Blood 72:1407-1411
16. Ketterling, RP Bottem CD Philip JA 3rd Sommer SS (1991) Evidence that descendants of three founders constitute about 25% of hemophilia B in the United States. Genomics 10:1093-1096